CD8A and toxoplasmosis: Currently, individual B (Darcy et al., 1992), CD4+ T (Grover et al., 2012), CD8+ T (Blanchard et al., 2008) cell epitopes have been able to induce partially protective immune responses against toxoplasmosis, and MAP vaccines are more likely to confer more robust protection (Bastos et al., 2016).